First Allied Advisory Services’s Novartis NVS Stock Holding History

First Allied Advisory Services’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.33M	Sell	15,250 -236	-2%	-$20.4K	0.04%	398
2020 Q2	$1.35M	Sell	15,486 -1,126	-7%	-$97.2K	0.05%	369
2020 Q1	$1.37M	Buy	16,612 +1,987	+14%	+$177K	0.06%	324
2019 Q4	$1.38M	Sell	14,625 -464	-3%	-$41.6K	0.05%	383
2019 Q3	$1.31M	Sell	15,089 -1,889	-11%	-$170K	0.05%	399
2019 Q2	$1.55M	Sell	16,978 -2,299	-12%	-$195K	0.05%	355
2019 Q1	$1.66M	Sell	19,277 -2,304	-11%	-$185K	0.06%	335
2018 Q4	$1.67M	Buy	21,581 +2,599	+14%	+$202K	0.07%	301
2018 Q3	$1.47M	Buy	18,982 +1,218	+7%	+$90K	0.05%	359
2018 Q2	$1.2M	Sell	17,764 -1,538	-8%	-$106K	0.05%	412
2018 Q1	$1.4M	Sell	19,302 -1,067	-5%	-$81.2K	0.05%	360
2017 Q4	$1.53M	Buy	20,369 +1,948	+11%	+$147K	0.06%	332
2017 Q3	$1.41M	Buy	18,421 +212	+1%	+$16K	0.06%	332
2017 Q2	$1.36M	Sell	18,209 -4,565	-20%	-$324K	0.06%	332
2017 Q1	$1.52M	Buy	22,774 +127	+0.6%	+$8.46K	0.08%	268
2016 Q4	$1.48M	Buy	22,647 +4,635	+26%	+$301K	0.07%	276
2016 Q3	$1.27M	Sell	18,012 -947	-5%	-$69K	0.07%	306
2016 Q2	$1.4M	Buy	18,959 +542	+3%	+$37.4K	0.08%	272
2016 Q1	$1.19M	Sell	18,417 -2,288	-11%	-$156K	0.07%	297
2015 Q4	$1.59M	Sell	20,705 -2,985	-13%	-$237K	0.08%	263
2015 Q3	$1.95M	Sell	23,690 -5,813	-20%	-$517K	0.11%	220
2015 Q2	$2.6M	Buy	29,503 +6,031	+26%	+$553K	0.12%	205
2015 Q1	$2.08M	Sell	23,472 -1,774	-7%	-$157K	0.14%	188
2014 Q4	$2.1M	Buy	25,246 +976	+4%	+$80.9K	0.15%	166
2014 Q3	$2.04M	Buy	24,270 +2,986	+14%	+$242K	0.16%	147
2014 Q2	$1.73M	Buy	21,284 +791	+4%	+$62.2K	0.13%	198
2014 Q1	$1.57M	Buy	20,493 +619	+3%	+$45.1K	0.12%	204
2013 Q4	$1.43M	Buy	19,874 +255	+1%	+$17.7K	0.11%	221
2013 Q3	$1.35M	Buy	19,619 +64	+0.3%	+$4.23K	0.08%	247
2013 Q2	$1.23M	Buy	+19,555	New	+$1.27M	0.1%	230

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

First Allied Advisory Services's NVS Position: Q3 2020 in Review

First Allied Advisory Services reduced its Novartis (NVS) stake by 1.5% in Q3 2020, selling an estimated $20.4K and leaving 15,250 shares worth $1.33M. The position accounts for 0.04% of the portfolio, ranked #398.

First Allied Advisory Services first reported a position in NVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.6M in Q2 2015. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

First Allied Advisory Services held 15,250 shares of Novartis worth $1.33M as of Q3 2020.
First Allied Advisory Services sold 236 Novartis shares in Q3 2020, an estimated $20.4K.
Novartis made up 0.04% of First Allied Advisory Services's portfolio in Q3 2020, its #398 holding.
First Allied Advisory Services first reported a position in Novartis in Q2 2013 and has held it in 30 quarters since.
First Allied Advisory Services's Novartis position peaked at $2.6M in Q2 2015.
1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.